Sona Nanotech Inc. (SNANF)
USD 0.18
(0.0%)
USD 0.18
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 527.68 Thousand CAD | -13.28% |
| 2022 | 608.46 Thousand CAD | -13.17% |
| 2021 | 700.76 Thousand CAD | 0.0% |
| 2020 | - CAD | -100.0% |
| 2019 | 666.81 Thousand CAD | 22.76% |
| 2018 | 543.18 Thousand CAD | 215.35% |
| 2017 | 172.24 Thousand CAD | -54.76% |
| 2016 | 380.7 Thousand CAD | -72.81% |
| 2015 | 1.4 Million CAD | -10.02% |
| 2014 | 1.55 Million CAD | 60.92% |
| 2013 | 967.12 Thousand CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| 2010 | - CAD | 0.0% |
| 2009 | - CAD | 0.0% |
| 2008 | - CAD | 0.0% |
| 2007 | - CAD | 0.0% |
| 2006 | - CAD | 0.0% |
| 2005 | - CAD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 587.18 Thousand CAD | 3.63% |
| 2024 Q1 | 546.81 Thousand CAD | 3.63% |
| 2024 Q2 | 566.63 Thousand CAD | 3.63% |
| 2023 FY | 527.68 Thousand CAD | -13.28% |
| 2023 Q2 | 653.28 Thousand CAD | 3.61% |
| 2023 Q4 | 527.68 Thousand CAD | -22.03% |
| 2023 Q1 | 630.5 Thousand CAD | 3.62% |
| 2023 Q3 | 676.81 Thousand CAD | 3.6% |
| 2022 Q2 | 752.49 Thousand CAD | 3.63% |
| 2022 Q3 | 587.17 Thousand CAD | -21.97% |
| 2022 Q4 | 608.46 Thousand CAD | 3.63% |
| 2022 FY | 608.46 Thousand CAD | -13.17% |
| 2022 Q1 | 726.16 Thousand CAD | 3.63% |
| 2021 Q1 | - CAD | 0.0% |
| 2021 Q3 | - CAD | 0.0% |
| 2021 FY | 700.76 Thousand CAD | 0.0% |
| 2021 Q4 | 700.76 Thousand CAD | 0.0% |
| 2021 Q2 | - CAD | 0.0% |
| 2020 Q3 | - CAD | 0.0% |
| 2020 Q1 | 682.52 Thousand CAD | 2.36% |
| 2020 FY | - CAD | -100.0% |
| 2020 Q4 | - CAD | 0.0% |
| 2020 Q2 | - CAD | -100.0% |
| 2019 Q2 | 700.85 Thousand CAD | 12.8% |
| 2019 FY | 666.81 Thousand CAD | 22.76% |
| 2019 Q1 | 621.3 Thousand CAD | 14.38% |
| 2019 Q4 | 666.81 Thousand CAD | -7.88% |
| 2019 Q3 | 723.83 Thousand CAD | 3.28% |
| 2018 Q3 | 295 Thousand CAD | 0.0% |
| 2018 Q1 | 292.5 Thousand CAD | 169715.26% |
| 2018 FY | 543.18 Thousand CAD | 215.35% |
| 2018 Q4 | 543.18 Thousand CAD | 84.13% |
| 2018 Q2 | 295 Thousand CAD | 0.85% |
| 2017 Q3 | 75.42 Thousand CAD | -40.0% |
| 2017 Q2 | 125.7 Thousand CAD | -71.33% |
| 2017 Q1 | 438.48 Thousand CAD | 15.18% |
| 2017 FY | 172.24 Thousand CAD | -54.76% |
| 2017 Q4 | 172.25 CAD | -99.77% |
| 2016 Q4 | 380.7 Thousand CAD | -4.43% |
| 2016 FY | 380.7 Thousand CAD | -72.81% |
| 2016 Q3 | 398.34 Thousand CAD | 1.92% |
| 2016 Q2 | 390.84 Thousand CAD | -72.24% |
| 2016 Q1 | 1.4 Million CAD | 0.54% |
| 2015 Q3 | 1.67 Million CAD | 6.86% |
| 2015 Q4 | 1.4 Million CAD | -16.34% |
| 2015 Q2 | 1.56 Million CAD | 11.38% |
| 2015 Q1 | 1.4 Million CAD | -9.64% |
| 2015 FY | 1.4 Million CAD | -10.02% |
| 2014 FY | 1.55 Million CAD | 60.92% |
| 2014 Q2 | 996.12 Thousand CAD | 1.48% |
| 2014 Q3 | 1.78 Million CAD | 79.55% |
| 2014 Q4 | 1.55 Million CAD | -12.99% |
| 2014 Q1 | 981.62 Thousand CAD | 1.5% |
| 2013 Q4 | 967.12 Thousand CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2013 FY | 967.12 Thousand CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2011 Q1 | - CAD | 0.0% |
| 2011 Q4 | - CAD | 0.0% |
| 2011 Q3 | - CAD | 0.0% |
| 2010 FY | - CAD | 0.0% |
| 2010 Q4 | - CAD | 0.0% |
| 2010 Q1 | - CAD | 0.0% |
| 2010 Q3 | - CAD | 0.0% |
| 2010 Q2 | - CAD | 0.0% |
| 2009 Q3 | - CAD | 0.0% |
| 2009 FY | - CAD | 0.0% |
| 2009 Q4 | - CAD | 0.0% |
| 2009 Q1 | - CAD | 0.0% |
| 2009 Q2 | - CAD | 0.0% |
| 2008 FY | - CAD | 0.0% |
| 2008 Q4 | - CAD | 0.0% |
| 2008 Q1 | - CAD | 0.0% |
| 2008 Q3 | - CAD | 0.0% |
| 2008 Q2 | - CAD | 0.0% |
| 2007 Q4 | - CAD | 0.0% |
| 2007 FY | - CAD | 0.0% |
| 2007 Q2 | - CAD | 0.0% |
| 2007 Q1 | - CAD | 0.0% |
| 2007 Q3 | - CAD | 0.0% |
| 2006 Q4 | - CAD | 0.0% |
| 2006 Q3 | - CAD | 0.0% |
| 2006 FY | - CAD | 0.0% |
| 2006 Q1 | - CAD | 0.0% |
| 2006 Q2 | - CAD | 0.0% |
| 2005 FY | - CAD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 6000.00 USD | -8694.683% |
| Arrayit Corporation | - USD | -Infinity% |
| Atlantic International Corp. | 1.29 Million USD | 59.331% |
| Biocept, Inc. | 10.37 Million USD | 94.914% |
| Bioqual, Inc. | - USD | -Infinity% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 51.3 Million USD | 98.972% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 61.22 Million USD | 99.138% |
| HTG Molecular Diagnostics, Inc. | 546.32 Thousand USD | 3.412% |
| iMD Companies, Inc. | 1.1 Million USD | 52.188% |
| IDenta Corp. | 428.17 Thousand USD | -23.239% |
| Interpace Biosciences, Inc. | 4.24 Million USD | 87.563% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | - USD | -Infinity% |
| Lumos Diagnostics Holdings Limited | - USD | -Infinity% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 278 Thousand USD | -89.813% |
| NovelStem International Corp. | 3.32 Million USD | 84.128% |
| Optigenex Inc. | 4.42 Million USD | 88.081% |
| PharmChem, Inc. | - USD | -Infinity% |
| Proteome Sciences plc | 1.63 Million USD | 67.647% |
| Response Genetics, Inc | 4.91 Million USD | 89.27% |
| Rennova Health, Inc. | 359.19 Thousand USD | -46.907% |
| RushNet, Inc. | 4.25 Million USD | 87.591% |
| ScreenPro Security Inc. | 249.05 Thousand USD | -111.878% |
| Stella Diagnostics Inc. | 798.44 Thousand USD | 33.911% |
| StageZero Life Sciences Ltd. | 576.38 Thousand USD | 8.449% |
| Todos Medical Ltd. | 33 Million USD | 98.401% |